Cost-utility of as-needed ICS-formoterol versus to maintenance ICS in mild to moderate persistent asthma

被引：0
|
作者：
Jefferson Antonio Buendía
Diana Guerrero Patiño
机构：
[1] University of Antioquia,Research Group in Pharmacology and Toxicology ”INFARTO”. Department of Pharmacology and Toxicology, Facultad de Medicina
[2] Hospital Infantil Concejo de Medellin,undefined
来源：
BMC Pulmonary Medicine | / 21卷
关键词：
Budesonide-formoterol; Uncontrolled asthma; Cost-effectiveness analysis; Decision analysis; Markov model;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [41] NUMBER NEEDED TO TREAT WITH AS-NEEDED BUDESONIDE/FORMOTEROL OR BUDESONIDE MAINTENANCE TO HAVE AN ADDITIONAL PATIENT FREE FROM A SEVERE OR MODERATE/SEVERE EXACERBATION: POST-HOC ANALYSIS OF SYGMA 1 IN MILD ASTHMA
    Reddel, H.
    O'Byrne, P.
    Bateman, D. E.
    Barnes, P.
    Zheng, J.
    Lamarca, R.
    Puu, M.
    Alagappan, V
    Fitzgerald, J.
    [J]. RESPIROLOGY, 2020, 25 : 106 - 106
  • [42] THE COST-EFFECTIVENESS OF BUDESONIDE/ FORMOTEROL MAINTENANCE AND RELIEVER THERAPY VERSUS SALMETEROL/FLUTICASONE PLUS AS-NEEDED SALBUTAMOL AMONG ASTHMA PATIENTS ≥12 YEARS IN CHINA
    Zhou, K.
    Xie, X.
    Zuo, C.
    Jiang, Y.
    Xuan, J.
    [J]. VALUE IN HEALTH, 2023, 26 (12) : S160 - S160
  • [43] Pharmacology Versus Convenience: A Benefit/Risk Analysis of Regular Maintenance Versus Infrequent or As-Needed Inhaled Corticosteroid Use in Mild Asthma
    Peter Daley-Yates
    Bhumika Aggarwal
    Zrinka Lulic
    Sourabh Fulmali
    Alvaro A. Cruz
    Dave Singh
    [J]. Advances in Therapy, 2022, 39 : 706 - 726
  • [44] Pharmacology Versus Convenience: A Benefit/Risk Analysis of Regular Maintenance Versus Infrequent or As-Needed Inhaled Corticosteroid Use in Mild Asthma
    Daley-Yates, Peter
    Aggarwal, Bhumika
    Lulic, Zrinka
    Fulmali, Sourabh
    Cruz, Alvaro A.
    Singh, Dave
    [J]. ADVANCES IN THERAPY, 2022, 39 (01) : 706 - 726
  • [45] Cost-utility analysis of inhaled corticosteroids administered daily or intermittently in patients with mild-persistent asthma
    Giglio, Norberto
    [J]. ARCHIVOS ARGENTINOS DE PEDIATRIA, 2014, 112 (06): : 579 - 580
  • [46] Regular versus as-needed budesonide and formoterol combination treatment for moderate asthma: a non-inferiority, randomised, double-blind clinical trial
    Papi, Alberto
    Marku, Brunilda
    Scichilone, Nicola
    Maestrelli, Piero
    Paggiaro, Pierluigi
    Saetta, Marina
    Nava, Stefano
    Folletti, Ilenia
    Bertorelli, Giuseppina
    Bertacco, Stefano
    Contoli, Marco
    Plebani, Mario
    Barbaro, Maria Pia Foschino
    Spanevello, Antonio
    Aliani, Maria
    Pannacci, Marco
    Morelli, Paolo
    Beghe, Bianca
    Fabbri, Leonardo M.
    [J]. LANCET RESPIRATORY MEDICINE, 2015, 3 (02): : 109 - 119
  • [47] Budesonide/formoterol as maintenance and reliever therapy compared to fixed-budesonide/formoterol plus albuterol reliever for pediatric asthma: A cost-utility analysis in Colombia
    Rodriguez-Martinez, Carlos E.
    Sossa-Briceno, Monica P.
    Nino, Gustavo
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2021, 9 (10): : 3816 - +
  • [48] Comparison of the Effects of Conventional Fixed ICS/LABA Combined Therapy Versus Combined Maintenance and Reliever ICS/Formoterol Therapy on the Treatment of Adherence and Inhaler Satisfaction of Asthma Patients Who Received Inhaler Education
    Gemicioglu, B.
    Sekibag, Y.
    Borekci, S.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2020, 201
  • [49] Tiotropium added to low- to medium-dose inhaled corticosteroids (ICS) versus low- to medium-dose ICS alone for adults with mild to moderate uncontrolled persistent asthma: A systematic review and meta-analysis
    Wang, Liqun
    Zhou, Ruirui
    Xie, Xiaohui
    [J]. JOURNAL OF ASTHMA, 2019, 56 (01) : 69 - 78
  • [50] Cost-effectiveness analysis of budesonide/formoterol SMART therapy versus salmeterol/fluticasone plus as-needed SABA among patients ≥12 years with moderate asthma from the Chinese societal perspective
    Zhou, Keruo
    Zhang, Min
    Zuo, Chenyu
    Xie, Xiazhen
    Xuan, Jianwei
    [J]. JOURNAL OF MEDICAL ECONOMICS, 2024, 27 (01) : 1018 - 1026
12345